Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy

Withdrawn before enrolling

Conditions studied: Breast Cancer

In brief

We will use magnetic resonance imaging (MRI) to investigate tumor changes in women with breast cancer who are receiving anthracycline-based systemic chemotherapy. We will also use MRI and cognitive tests to study the possible effects of chemotherapy on the brains of these women. The results will be compared to a control group of normal healthy women. We will try to determine if MRI can be used to predict tumor response and cognitive changes related to the chemotherapy.

Key facts

Study ID

NCT01045044

Run by

Kettering Health Network

People needed

0

Starts

2009-12-01

Expected to finish

2011-10-01

Last updated by the study team

2012-04-05

Who can join

Age: 18 and older, up to 65. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Diagnosed with Adenocarcinoma(ER+ve, PR+ve)
• Prescribed, but not yet begun, anthracycline based systemic chemotherapy
• Not prescribed Avastin
• Able to read and write in English
• Have signed informed consent

You may not qualify if…

• Diagnosed psychiatric disorder
• Conditions that would preclude MRI (Pacemaker, metal objects in body, claustrophobia, pregnancy, etc.)
• Serious, unstable medical or mental illness
• Medical contraindication to any study procedure
• Current alcohol or other substance use disorder (excluding nicotine)
• Have not read and signed informed consent, or do not understand its contents

Where it is running

• Medical Oncology Hematology Associates, Inc — Dayton, Ohio, United States
• Innovation Center, Kettering Health Network — Kettering, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.